Imadeldin Elfaki
Overview
Explore the profile of Imadeldin Elfaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdulla A, Sadida H, Jerobin J, Elfaki I, Mir R, Mirza S, et al.
J Natl Cancer Cent
. 2025 Mar;
5(1):8-27.
PMID: 40040878
Obesity, a global health concern, is associated with severe health issues like type 2 diabetes, heart disease, and respiratory complications. It also increases the risk of various cancers, including melanoma,...
2.
Elfaki I, Mir R, Elnageeb M, Hamadi A, Alharbi Z, Bedaiwi R, et al.
Medicina (Kaunas)
. 2025 Jan;
61(1).
PMID: 39859066
Metabolic syndrome is a metabolic disorder characterized by hypertension, dyslipidemia, impaired glucose tolerance, and abdominal obesity. Impaired insulin action or insulin resistance initiates metabolic syndrome. The prevalence of insulin resistance...
3.
Mir R, Altemani F, Algehainy N, Alanazi M, Elfaki I, Alsayed B, et al.
Biochem Genet
. 2025 Jan;
PMID: 39833648
No abstract available.
4.
Javid J, Mir R, Elfaki I, Almotairi R, Barnawi J, Algehainy N, et al.
Discov Med
. 2024 Nov;
36(190):2287-2299.
PMID: 39600283
Background: Insufficient vitamin D (vit D) levels are associated with various chronic conditions such as cancers, autoimmune diseases, diabetes, and cardiovascular diseases, notably coronary artery disease (CAD). The enzyme 25-hydroxylase,...
5.
Mir R, Altemani F, Altemani F, Algehainy N, Alanazi M, Elfaki I, et al.
Biochem Genet
. 2024 Nov;
PMID: 39557769
Covid-19 caused by SARS-CoV-2 virus has emerged as an immense burden and an unparalleled global health challenge in recorded human history. The clinical characteristics and risk factors of COVID-19 exhibit...
6.
Mir R, Baba S, Elfaki I, Algehainy N, Alanazi M, Altemani F, et al.
J Cancer
. 2024 Nov;
15(19):6383-6415.
PMID: 39513123
Extracellular vehicles (EVs) are gaining increasing recognition as central contributors to the intricate landscape of the tumor microenvironment (TME). This manuscript provides an extensive examination of the multifaceted roles played...
7.
Jalal M, Algamdi M, Alkayyal A, Altayar M, Mouminah A, Alamrani A, et al.
Med Int (Lond)
. 2024 Sep;
4(6):69.
PMID: 39301327
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) illness led to the coronavirus disease 2019 (COVID-19) pandemic, which has caused enormous health and financial losses, as well as challenges to...
8.
Mir M, Alfaifi J, Sohail S, Rizvi S, Akhtar M, Alghamdi M, et al.
J Pers Med
. 2024 Jul;
14(7).
PMID: 39063997
Background: Type 2 diabetes mellitus (T2DM) is becoming a major global health concern, especially in developing nations. The high prevalence of obesity and related diabetes cases are attributed to rapid...
9.
Mir R, Elfaki I, Alanazi M, Algehainy N, Altemani F, Alsayed B, et al.
Discov Med
. 2024 Jul;
36(186):1513-1526.
PMID: 39054721
Background: In recent years, various coronaviruses have caused severe respiratory illnesses worldwide. For example the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections of COVID-19 outbreak in 2019 in Wuhan, China....
10.
Elangeeb M, Elfaki I, Eleragi A, Ahmed E, Mir R, Alzahrani S, et al.
Molecules
. 2024 Apr;
29(8).
PMID: 38675722
Diabetes mellitus (DM) represents a problem for the healthcare system worldwide. DM has very serious complications such as blindness, kidney failure, and cardiovascular disease. In addition to the very bad...